Dysfunctional Glucose Metabolism in Alzheimer’s Disease Onset and Potential Pharmacological Interventions
Alzheimer’s disease (AD) is the most common age-related dementia. The alteration in metabolic characteristics determines the prognosis. Patients at risk show reduced glucose uptake in the brain. Additionally, type 2 diabetes mellitus increases the risk of AD with increasing age. Therefore, changes i...
Main Authors: | Vijay Kumar, So-Hyeon Kim, Kausik Bishayee |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/17/9540 |
Similar Items
-
Dementia-related genetic variants in an Italian population of early-onset Alzheimer’s disease
by: Anna Bartoletti-Stella, et al.
Published: (2022-09-01) -
Longitudinal Consumption of Ergothioneine Reduces Oxidative Stress and Amyloid Plaques and Restores Glucose Metabolism in the 5XFAD Mouse Model of Alzheimer’s Disease
by: Clayton A. Whitmore, et al.
Published: (2022-06-01) -
Glucose Deprivation Induces Cancer Cell Death through Failure of ROS Regulation
by: Mingyu Kang, et al.
Published: (2023-07-01) -
Elevated CLOCK and BMAL1 Contribute to the Impairment of Aerobic Glycolysis from Astrocytes in Alzheimer’s Disease
by: Ik Dong Yoo, et al.
Published: (2020-10-01) -
Genetic profiles of familial late-onset Alzheimer's disease in China: The Shanghai FLOAD study
by: Xin-Yi Xie, et al.
Published: (2022-11-01)